RecruitingNot ApplicableNCT07321353

Survivors Journey+

Online Problem-Solving Intervention for Brain Tumor Survivors: A Two-site, Two-arm Pilot Randomized Controlled Trial


Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment

72 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The main goal of this pilot randomized controlled trial is to learn if an online program called "Survivors Journey" (SJ+) can help teens and young adults, ages 15-25, who are Pediatric Brain Tumor Survivors (PBTS), and their caregivers, manage everyday challenges better by using skills like problem-solving and coping skills. The main questions it aims to answer are: * Is the SJ+ program rated as feasible (\>50% enrollment rate and \>75% retention rate) and acceptable (\>80% satisfaction rate) by PBTS and their caregivers? * Does the SJ+ program have better outcomes in improving PBTS and caregiver wellbeing in comparison to an internet resource comparison (IRB) made for PBTS and their families? Participants will be randomized into two groups: one group will be given access to the online SJ+ program and receive weekly online coaching sessions, and the other group will be given access to an IRC. Outcomes will be assessed at baseline, treatment completion (\~ 3 months post-baseline), and at follow-up six months post-baseline. These outcomes include quality of life, internalizing symptoms, performance-based executive function skills, depression, and family impact.


Eligibility

Min Age: 15 YearsMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This study — called Survivors Journey+ — is designed to support children who have survived a brain tumor and now live with the long-term effects of their cancer treatment. The program aims to help both the child and their family cope and thrive after cancer. **You may be eligible if...** - Your child was diagnosed with a brain tumor (inside the skull) - Treatment (surgery, radiation, or chemotherapy) was completed more than 12 months ago - Your child lives with a parent or guardian - English is the main language spoken at home **You may NOT be eligible if...** - Your child has a diagnosis of tuberous sclerosis or neurofibromatosis - Treatment finished less than 12 months ago, or did not include surgery, radiation, or chemotherapy - Your child has a history of being hospitalized for psychiatric reasons - Your child has autism, reactive attachment disorder, psychosis, or a condition associated with risk of harm to self or others - Your child does not live in the family home - English is not the primary language at home Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSurvivor's Journey+

Our overarching objectives are to: 1) to refine the existing program based on feedback from patient advocates and establish usability and accessibility; 2) examine the efficacy of SJ+ in improving global QoL, internalizing symptoms, and EF skills in adolescent/emerging adult PBTS; and 3) examine the efficacy of SJ+ in reducing caregiver depression and family impact.


Locations(2)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Nationwide Children's Hospital

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07321353


Related Trials